What is the starting dose of Flexiril (cyclobenzaprine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flexiril (Cyclobenzaprine) Starting Dose

The recommended starting dose of Flexiril (cyclobenzaprine) is 5 mg three times a day. 1

Dosing Guidelines

Initial Dosing

  • Start with 5 mg three times daily
  • Based on individual response, may increase to 10 mg three times daily 1

Duration of Treatment

  • Not recommended for use longer than 2-3 weeks 1
  • Clinical trials have shown efficacy within the first week of treatment 2

Special Populations

  • Elderly patients: Consider less frequent dosing 1
  • Hepatically impaired patients: Consider less frequent dosing 1

Evidence for Dosing Recommendations

The FDA-approved dosing recommendation is based on clinical evidence showing that:

  • The 5 mg three times daily regimen is as effective as 10 mg three times daily for most patients 2
  • The 5 mg dose is associated with fewer side effects, particularly sedation, compared to the 10 mg dose 2
  • Lower doses (2.5 mg three times daily) have not shown significant efficacy compared to placebo 2

Extended-Release Formulation

For the extended-release formulation:

  • Starting dose is 15 mg once daily 3
  • May be increased to 30 mg once daily if needed 3
  • Provides comparable systemic exposure to immediate-release 10 mg three times daily 4

Common Side Effects

The most common adverse effects are dose-related and include:

  • Somnolence/drowsiness
  • Dry mouth
  • Dizziness
  • Constipation
  • Headache 2, 3

Clinical Pearls

  • Onset of relief is typically apparent within 3-4 doses of the 5 mg regimen 2
  • Cyclobenzaprine's efficacy in fibromyalgia has been evaluated, with 85% of patients experiencing side effects and 29% discontinuing treatment 5
  • Combination therapy with cyclobenzaprine 5 mg TID plus ibuprofen has not shown superior efficacy compared to cyclobenzaprine 5 mg TID alone for acute neck and back pain with muscle spasm 6
  • Serious toxicity is infrequent with doses less than 100 mg in overdose situations 7

Monitoring

  • Monitor for sedation, particularly at the beginning of treatment
  • Assess efficacy within the first few days of treatment
  • Consider discontinuation if no improvement after 2-3 weeks

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.